74.44 USD
+1.58 (+2.17%)
74.44 USD
0 (0%)
Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 100 industry peers in the Health Care Providers & Services industry. While HSIC is still in line with the averages on profitability rating, there are concerns on its financial health. HSIC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
HSIC had a positive operating cash flow in the past year.
Each year in the past 5 years HSIC has been profitable.
In the past 5 years HSIC always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 3.52%, HSIC is doing good in the industry, outperforming 66.00% of the companies in the same industry.
HSIC has a Return On Equity of 11.63%. This is in the better half of the industry: HSIC outperforms 76.00% of its industry peers.
HSIC's Return On Invested Capital of 6.64% is fine compared to the rest of the industry. HSIC outperforms 66.00% of its industry peers.
HSIC had an Average Return On Invested Capital over the past 3 years of 8.02%. This is in line with the industry average of 9.42%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROIC | 6.64% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
HSIC's Profit Margin of 3.02% is fine compared to the rest of the industry. HSIC outperforms 66.00% of its industry peers.
In the last couple of years the Profit Margin of HSIC has declined.
With a decent Operating Margin value of 5.94%, HSIC is doing good in the industry, outperforming 63.00% of the companies in the same industry.
In the last couple of years the Operating Margin of HSIC has declined.
HSIC has a Gross Margin of 31.19%. This is comparable to the rest of the industry: HSIC outperforms 59.00% of its industry peers.
In the last couple of years the Gross Margin of HSIC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
HSIC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HSIC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for HSIC has been reduced compared to 5 years ago.
The debt/assets ratio for HSIC is higher compared to a year ago.
2.2 Solvency
HSIC has an Altman-Z score of 2.62. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score of 2.62. This is comparable to the rest of the industry: HSIC outperforms 55.00% of its industry peers.
The Debt to FCF ratio of HSIC is 8.70, which is on the high side as it means it would take HSIC, 8.70 years of fcf income to pay off all of its debts.
HSIC has a Debt to FCF ratio of 8.70. This is comparable to the rest of the industry: HSIC outperforms 51.00% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that HSIC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.91, HSIC is in line with its industry, outperforming 42.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Altman-Z | 2.62 |
ROIC/WACC0.79
WACC8.45%
2.3 Liquidity
HSIC has a Current Ratio of 1.40. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.40, HSIC perfoms like the industry average, outperforming 51.00% of the companies in the same industry.
HSIC has a Quick Ratio of 1.40. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HSIC (0.79) is worse than 76.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.49%, which is quite good.
HSIC shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.19% yearly.
Looking at the last year, HSIC shows a small growth in Revenue. The Revenue has grown by 3.51% in the last year.
The Revenue has been growing slightly by 4.88% on average over the past years.
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
3.2 Future
The Earnings Per Share is expected to grow by 8.14% on average over the next years. This is quite good.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.28% on average per year.
EPS Next Y5.82%
EPS Next 2Y6.69%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 15.44 indicates a correct valuation of HSIC.
81.00% of the companies in the same industry are more expensive than HSIC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HSIC to the average of the S&P500 Index (26.28), we can say HSIC is valued slightly cheaper.
With a Price/Forward Earnings ratio of 13.80, HSIC is valued correctly.
Based on the Price/Forward Earnings ratio, HSIC is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.52. HSIC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.44 | ||
| Fwd PE | 13.8 |
4.2 Price Multiples
73.00% of the companies in the same industry are more expensive than HSIC, based on the Enterprise Value to EBITDA ratio.
HSIC's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.62 | ||
| EV/EBITDA | 9.89 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.65
PEG (5Y)2.49
EPS Next 2Y6.69%
EPS Next 3Y7.97%
5. Dividend
5.1 Amount
HSIC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
74.44
+1.58 (+2.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners97.3%
Inst Owner Change-5%
Ins Owners0.79%
Ins Owner Change-0.09%
Market Cap8.76B
Revenue(TTM)12.94B
Net Income(TTM)391.00M
Analysts71.82
Price Target78.7 (5.72%)
Short Float %7.05%
Short Ratio4.85
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.88%
Min EPS beat(2)-9.54%
Max EPS beat(2)5.78%
EPS beat(4)2
Avg EPS beat(4)-1.38%
Min EPS beat(4)-9.54%
Max EPS beat(4)5.78%
EPS beat(8)4
Avg EPS beat(8)-0.56%
EPS beat(12)5
Avg EPS beat(12)-0.94%
EPS beat(16)7
Avg EPS beat(16)0.24%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-0.09%
Revenue beat(4)0
Avg Revenue beat(4)-2.59%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-0.09%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)0
Avg Revenue beat(12)-3.01%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)5.1%
PT rev (3m)5.04%
EPS NQ rev (1m)0.27%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)1.98%
EPS NY rev (3m)1.92%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.68%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)0.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.44 | ||
| Fwd PE | 13.8 | ||
| P/S | 0.68 | ||
| P/FCF | 24.62 | ||
| P/OCF | 16.38 | ||
| P/B | 2.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.89 |
EPS(TTM)4.82
EY6.48%
EPS(NY)5.4
Fwd EY7.25%
FCF(TTM)3.02
FCFY4.06%
OCF(TTM)4.54
OCFY6.11%
SpS109.9
BVpS28.55
TBVpS-15.56
PEG (NY)2.65
PEG (5Y)2.49
Graham Number55.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.52% | ||
| ROE | 11.63% | ||
| ROCE | 9.68% | ||
| ROIC | 6.64% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 16.65% | ||
| OM | 5.94% | ||
| PM (TTM) | 3.02% | ||
| GM | 31.19% | ||
| FCFM | 2.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexgc growth 3Y-9.94%
ROICexgc growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.91 | ||
| Debt/FCF | 8.7 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 58.69% | ||
| Cap/Sales | 1.38% | ||
| Interest Coverage | 5.16 | ||
| Cash Conversion | 49.81% | ||
| Profit Quality | 91.05% | ||
| Current Ratio | 1.4 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.62 |
F-Score5
WACC8.45%
ROIC/WACC0.79
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)14.49%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%13.11%
EPS Next Y5.82%
EPS Next 2Y6.69%
EPS Next 3Y7.97%
EPS Next 5Y8.14%
Revenue 1Y (TTM)3.51%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%5.2%
Revenue Next Year2.47%
Revenue Next 2Y2.91%
Revenue Next 3Y3.2%
Revenue Next 5Y3.28%
EBIT growth 1Y26.48%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year15.69%
EBIT Next 3Y8.36%
EBIT Next 5Y7.01%
FCF growth 1Y-45.15%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-31.93%
OCF growth 3Y6.12%
OCF growth 5Y4.66%
HENRY SCHEIN INC / HSIC FAQ
Can you provide the ChartMill fundamental rating for HENRY SCHEIN INC?
ChartMill assigns a fundamental rating of 4 / 10 to HSIC.
Can you provide the valuation status for HENRY SCHEIN INC?
ChartMill assigns a valuation rating of 5 / 10 to HENRY SCHEIN INC (HSIC). This can be considered as Fairly Valued.
Can you provide the profitability details for HENRY SCHEIN INC?
HENRY SCHEIN INC (HSIC) has a profitability rating of 6 / 10.
What is the earnings growth outlook for HENRY SCHEIN INC?
The Earnings per Share (EPS) of HENRY SCHEIN INC (HSIC) is expected to grow by 5.82% in the next year.